MetLife Investment Management’s Braze BRZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Buy
59,382
+12,151
+26% +$263K 0.01% 1244
2025
Q4
$1.62M Buy
47,231
+890
+2% +$26.4K 0.01% 1182
2025
Q3
$1.32M Buy
46,341
+516
+1% +$14.6K 0.01% 1304
2025
Q2
$1.29M Buy
45,825
+6,294
+16% +$199K 0.01% 1183
2025
Q1
$1.43M Sell
39,531
-685
-2% -$27.6K 0.01% 1201
2024
Q4
$1.68M Buy
40,216
+2,572
+7% +$93.3K 0.01% 1134
2024
Q3
$1.22M Buy
37,644
+6,955
+23% +$275K 0.01% 1280
2024
Q2
$1.19M Buy
30,689
+3,005
+11% +$120K 0.01% 1251
2024
Q1
$1.23M Hold
27,684
0.01% 1184
2023
Q4
$1.47M Hold
27,684
0.01% 1105
2023
Q3
$1.29M Buy
27,684
+9,336
+51% +$410K 0.01% 1102
2023
Q2
$803K Buy
+18,348
New +$624K 0.01% 1392

Other funds holding BRZE

MetLife Investment Management's BRZE Position: Q1 2026 in Review

MetLife Investment Management increased its Braze (BRZE) stake by 26% in Q1 2026, buying an estimated $263K and bringing the position to 59,382 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #1244.

MetLife Investment Management first reported a position in BRZE in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.68M in Q4 2024. 257 funds tracked by Wall St. Rank hold BRZE as of Q1 2026.

  • MetLife Investment Management held 59,382 shares of Braze worth $1.4M as of Q1 2026.
  • MetLife Investment Management bought 12,151 Braze shares in Q1 2026, an estimated $263K.
  • Braze made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1244 holding.
  • MetLife Investment Management first reported a position in Braze in Q2 2023 and has held it in 12 quarters since.
  • MetLife Investment Management's Braze position peaked at $1.68M in Q4 2024.
  • 257 funds tracked by Wall St. Rank held Braze as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.